Drug alert number: EL (24)A/50 Date issued: 23 October 2024 Bristol Laboratories Ltd. are recalling one batch of Phenobarbital Bristol Labs 15mg Tablets as a precautionary measure due to the potential of contamination of small metallic particles within the tablets. PL 17907/0175 DMRC Number: DMRC-32910584 SNOMED Code:21039211000001106 Batch No Expiry Date Pack Size First Distributed
Read moreThe Secretary of State for Health and Social Care has this week launched a national conversation on the NHS, seeking input and ideas to shape the future of a reformed health service. Patients, members of the public and anyone working in the NHS have been invited to submit their views and ideas via the change.nhs.uk portal.
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (22/10/2024) announced the following list of price concessions for October 2024: Drug Pack size Price concession Agomelatine 25mg tablets 28 £13.50 Amitriptyline 50mg/5ml oral solution sugar free 150
Read moreNational Patient Safety Alert: Discontinuation of Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup National Patient Safety Alert Reference Number: NatPSA/2024/011/DHSC Date issued: 21-Oct-2024 This NatPSA supersedes NatPSA/2024/008/DHSC This alert is for action by: All organisations involved in prescribing, dispensing and administering Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup. This is a safety critical
Read moreMHRA Class 4 Medicines Defect Information: Paracetamol 500mg Effervescent Tablets (Kent Pharma UK) Drug alert number: EL(24)A/49 Date issued: 21 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Paracetamol 500mg Effervescent Tablets (Kent Pharma UK) Company name: Kent Pharma UK Product name: Paracetamol
Read moreCommunity pharmacy owners are being asked to share their views and concerns as we head into winter, as well as any further feedback they have, before the next full Community Pharmacy England Committee meeting in November. This winter will be a critical time for the sector as community pharmacy owners desperately need answers about their
Read moreStaffing pressures are significantly impacting community pharmacies, adding huge workload pressures for all those who work in them and hampering their ability to help patients and the public, a report from Community Pharmacy England has found. Pharmacy owners and team members across England paint a vivid picture of the severe consequences caused by staffing shortages,
Read moreCommunity pharmacy has been referenced several times in the Houses of Parliament this week as MPs have quizzed Health Ministers on access to primary care services and pharmacy funding during two sessions. During Health Questions on Tuesday, Warinder Juss MP (Labour) enquired about the level of patient access to primary care services. In response the
Read moreCommunity Pharmacy England CEO Janet Morrison gave an important sector update at this week’s Pharmacy Show, while other members of the team joined other key sessions and engaged with visitors to our exhibition stand. Thank you to all community pharmacy owners and others who took this opportunity to engage with us, sharing views and asking
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens MSN/2024/103 Tier 2 – medium impact Date of issue: 16th October 2024 TO NOTE: This is the first of three MSNs covering discontinuations with Novo Nordisk insulin products (NovoRapid® FlexTouch®,
Read more
